<![CDATA[Novo Nordisk A/S - Stock Exchange Announcements]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Trading in Novo Nordisk shares by board members, executives and associated persons as reported to Novo Nordisk on 30 October 2009]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Trading in Novo Nordisk shares by board members, executives and associated persons as reported to Novo Nordisk on 29 October 2009]]><![CDATA[Interim financial report for the period 1 January 2009 to 30 September 2009]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Status regarding Novo Nordisk's holding of its own shares (30 September 2009)]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Update on timeline for formal feedback on liraglutide from the FDA]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]><![CDATA[Novo Nordisk A/S - Share repurchase programme]]>